Is the space between the executive suite at these multi-billion, diversified orthopedic companies in Indiana, Tennessee or Michigan and the rank and file orthopedic surgeon now a chasm of Grand Canyon proportions?
The team at Iconacy Orthopedic Implants, LLC in Warsaw thinks so and have decided to do their level best to correct the problem.
Earlier last month, the young company announced that it had received its first FDA clearance to market a total hip replacement system under the trademark name I-Hip. The company defines the I-Hip system as consisting of “femoral stem and acetabular cup porous coated components intended for cement-less, press-fit fixation, patented highly cross-linked polyethylene liners, and Co-Cr alloy femoral heads.”
Products such as the I-Hip system align well with our overall strategy of providing clinically proven geometries of the highest quality while advancing technology, ” said Kevin Cox, VP of Sales and Marketing. “This system will allow us to deliver a best in class hip with advanced wear characteristics at an optimum value.
According to its press release, ICONACY was founded in 2009 “with a view focusing on the needs of patients, surgeons, and hospitals without the bureaucracy and costly infrastructure of a large organization.” The company plans to produce all of its products—hip, knee and shoulder replacements—in the United States.
